COMPANY
Rock Immune
Rock Immune is an early-stage biopharmaceutical company developing diphtheria toxin-based recombinant immunotoxins for cancer and autoimmune diseases; its drug candidates include a CCR4-IL2 bispecific immunotoxin for cutaneous T-cell lymphoma. Source